VIEMED HEALTHCARE, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M |
| Gross profit | $155.5M | $133.2M | $112.8M | $84.7M | $73.4M |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M |
| Cost of revenue | $114.8M | $91.1M | $70.2M | $54.2M | $43.7M |
| Cash from operations | $51.9M | $39.1M | $45.2M | $27.7M | $22.5M |
| Capital expenditure | $40.0M | $37.8M | $26.1M | $22.9M | $19.7M |
| Free cash flow | $11.9M | $1.3M | $19.1M | $4.8M | $2.8M |
| Share repurchases | $13.2M | $0 | $0 | $9.6M | $0 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $199.2M | $177.1M | $154.9M | $117.0M | $118.0M |
| Total liabilities | $55.6M | $43.8M | $41.0M | $19.9M | $23.1M |
Shares outstanding 38.3M · Free float 64.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.